GlassScriptPhysician profile
Hilton Kit Howard
NPI 1548259443
$2,607.34
in general payments reported to CMS, 2019-2025
23 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $503 · 2020: $188 · 2021: $482 · 2022: $364 · 2023: $698 · 2024: $183 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $970 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $969.51 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $775.07 | 2019-2023 | |
| Astellas Pharma US INC | $633.56 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $193.75 | 2020-2022 | |
| Coopersurgical, INC. | $104.27 | 2019-2024 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $98.54 | 2023-2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $86.51 | 2019-2025 | |
| Organon LLC | $83.58 | 2021-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $80.49 | 2019-2025 | Aptima |
| Mayne Pharma Commercial LLC | $78.84 | 2022-2025 | |
| Avion Pharmaceuticals | $72.91 | 2019-2023 | Balcoltra |
| Myovant Sciences INC. | $72.31 | 2021 | |
| Therapeuticsmd, INC. | $70.26 | 2019-2021 | |
| Millicent US INC | $64.62 | 2019-2025 | Intrarosa, Femlyv |
| Takeda Pharmaceuticals U.S.A., INC. | $38.92 | 2021 | |
| Duchesnay USA Incorporated | $36.08 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $20.02 | 2023 | Accrufer |
| Medtronic, INC. | $19.96 | 2024 | Interstim |
| Evofem Biosciences, INC. | $19.60 | 2021-2025 | Solosec, Phexx, Phexxi |
| Allergan, INC. | $12.64 | 2019 | |
| Roche Diagnostics Corporation | $12.45 | 2019 | |
| Merck Sharp & Dohme LLC | $11.94 | 2019 | |
| Virtus Pharmaceuticals LLC | $11.42 | 2021 | |
| Channel Medsystems, INC. | $9.60 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hilton Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.